Fill This Form To Receive Instant Help
Homework answers / question archive / University of Illinois, Chicago NURS 531 Chapter 22: The vascular system MULTIPLE CHOICE 1)Which vasoconstrictor substance is produced by vascular endothelial cells? nitric oxide bradykinin prostacyclin natriuretic peptide endothelin 2
2. The opening of membrane potassium channels by minoxidil leads to
3. Both valsartan and enalapril
4. Bosentan is an antagonist of
5. In persons with heart failure, enalapril typically increases
6. Which drug reduces sympathetic outflow from the central nervous system?
7. |
Captopril is a structural analog of the terminal dipeptide of |
1. |
renin |
2. |
nitric oxide synthase |
3. |
endothelin |
4. |
angiotensin converting enzyme |
5. |
angiotensin I |
|
|
8. |
Effects similar to those of angiotensin converting enzyme inhibitors may be obtained in heart failure patients |
|
by administering |
1. |
furosemide |
2. |
digoxin |
3. |
hydralazine and isosorbide dinitrate |
4. |
dobutamine |
5. |
nitroglycerin |
|
|
9. |
The adverse effects of terazosin and related drugs typically include |
1. |
hypokalemia |
2. |
drowsiness and dry mouth |
3. |
urinary retention in older men |
4. |
postural hypotension and edema |
5. |
bradycardia and syncope |
|
|
10. |
In persons with decompensated heart failure, nesiritide activates |
1. |
adrenergic alpha receptors |
2. |
adrenergic beta receptors |
3. |
adenylate cyclase |
4. |
guanylate cyclase |
5. |
myosin phosphatase |
|
|
11. |
The preferred drugs for the initial treatment of most patients with mild hypertension include |
1. |
hydralazine |
2. |
minoxidil |
3. |
hydrochlorothiazide |
4. |
methyldopa |
5. |
prazosin |
|
|
12. |
Fenoldopam is useful in treating hypertensive emergencies because of its ability to |
1. |
block adrenergic beta receptors |
2. |
block adrenergic alpha receptors |
3. |
block calcium channels |
4. |
open potassium channels |
5. activate dopamine D1 receptors
13. Beginning therapy with low doses that are gradually increased over several months is appropriate when treating heart failure with
14. The progression of diabetic nephropathy may be slowed by
15. The use of eplerenone in the treatment of heart failure is based on its ability to